PureTech Health (PRTC) Non-Current Deferred Tax Liability (2019 - 2023)
PureTech Health (PRTC) reported Non-Current Deferred Tax Liability of $1.9 million for Q4 2023, down 97.88% on a QoQ basis from $89.8 million in Q4 2021.
PureTech Health (PRTC) has 4 years of Non-Current Deferred Tax Liability data on file, last reported at $1.9 million in Q4 2023.
- Quarterly Non-Current Deferred Tax Liability changed N/A year-over-year to $1.9 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.9 million (changed N/A YoY) and the FY2023 annual result came in at $1.9 million, changed N/A from the prior year.
- Non-Current Deferred Tax Liability fell to $1.9 million in Q4 2023 per PRTC's latest filing, from $89.8 million in the prior quarter.
- Across five years, Non-Current Deferred Tax Liability topped out at $115.4 million in Q4 2019 and bottomed at $1.9 million in Q4 2023.
- The 4-year median for Non-Current Deferred Tax Liability is $99.2 million (2020), against an average of $78.9 million.
- The widest annual swing landed in 2020, when Non-Current Deferred Tax Liability dropped 5.91%; it then slipped 17.36% in 2021.
- Tracing PRTC's Non-Current Deferred Tax Liability over 4 years: stood at $115.4 million in 2019, then dropped by 5.91% to $108.6 million in 2020, then fell by 17.36% to $89.8 million in 2021, then slumped by 97.88% to $1.9 million in 2023.
- Per Business Quant, the three latest PRTC Non-Current Deferred Tax Liability figures stand at $1.9 million (Q4 2023), $89.8 million (Q4 2021), and $108.6 million (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2023 | 1.90 Mn |
| Dec 31, 2021 | 89.77 Mn |
| Dec 31, 2021 | 89.77 Mn |
| Dec 31, 2020 | 108.63 Mn |
| Dec 31, 2020 | 108.63 Mn |
| Dec 31, 2019 | 115.45 Mn |
| Dec 31, 2019 | 115.45 Mn |